05

U&I Corporation

056090 · KQ · Healthcare / Medical Devices

4,165.00KRW+15.00 (+0.36%)

Price History

Full chart

Market Stats

Previous Close4,150.00
Open4,085.00
Day Range4,085.00 – 4,290.00
52-Week Range850.00 – 3,555.00
Volume42.41K
Market Cap122.88B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.08
50-Day Avg1,113.60
200-Day Avg1,587.86

About

CG MedTech Co.,Ltd. researches, develops, manufactures, and sale of orthopedic medical devices in the healthcare service market. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cervical cages for cervical interbody fusion; and Velofix PEEK cage; and NeoIC PEEK cage, devices used with autograft or bone graft substitutes, as well as UniSpace Stand-Alone C Cage, a standalone anterior cervical interbody fusion device. It also provides Benefix interspinous fixation systems for the immobilization and stabilization of the spinous processes; ANAX 5.5 posterior spinal fixation system; ANAX 5.5 MIS System, ANAX 5.5 CT Spinal System, U&I Retractor; Perfix spinal system, a posterior and non-cervical pedicle fixation system, that includes Iliac screw, MIS system, level extension device; Spinal Hook system that provides distraction, compression, axial rotation, and anterior-posterior correction of deformities from thoracic spine to sacral spine; and Neo IC Cylindrical, Velofix TLIF cage, and Neo IC Square cage, as well as INNOVERSE spinal system. In addition, the company provides Polarfix facet screw fixation system, SECULOK interference screw and shoulder anchor; PRO-DENSE Bone graft substitute, MIIG X3 injectable graft, and OSTEOSET products, as well as LIFEGRAFT. Further, it offers Dyna Locking Trochanteric Nail; Dyna Locking Ankle Nail; Dyna Locking IM Nail; Dyna Locking Cannulated Screw; EXPEDIO balloon catheter, an interventional medical device; and L'DISQ for radicular and discogenic pain, as well as velofuse gel and putty, an injectable demineralized bone fiber. The company was formerly known as Innosys Co., Ltd. and changed its name to CG MedTech Co.,Ltd. in November 2024. The company was founded in 1993 and is headquartered in Uijeongbu-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOJu mi Chung
  • Employees122
  • Headquarters20, Sandan-ro, Uijeongbu-si, South Korea, 11781, Korea
  • Websitehttps://www.cgmedt.com

Leadership

  • Ju mi ChungChief Executive Officer
  • Y. J. OhDirector of Marketing

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue14.60B11.69B13.29B31.69B34.81B27.78B38.06B41.17B34.97B34.62B47.23B
Growth (%)--19.93%+13.74%+138.35%+9.87%-20.22%+37.01%+8.18%-15.06%-0.99%+36.43%
Cost of Revenue5.19B5.32B9.13B20.84B21.07B21.59B22.20B22.12B16.71B18.50B26.08B
Gross Profit9.41B6.37B4.16B10.84B13.74B6.18B15.86B19.05B18.26B16.13B21.16B
Gross Margin64.47%54.47%31.31%34.22%39.48%22.26%41.67%46.28%52.22%46.57%44.79%
Operating Expense11.03B9.55B9.50B26.06B14.88B16.99B20.94B18.65B15.20B17.22B17.34B
Operating Income-1.62B-3.19B-5.34B-15.22B-1.13B-10.80B-5.08B404.62M3.06B-1.10B3.82B
Operating Margin-11.08%-27.25%-40.17%-48.02%-3.25%-38.90%-13.36%0.98%8.74%-3.17%8.08%
EBITDA--------9.90B3.78B1.89B5.18B
EBITDA Margin--------24.06%10.80%5.46%10.96%
Net Income-810.81M-2.08B-6.54B-14.72B-1.89B-12.28B-4.97B-18.54B1.63B59.69M6.51B
Net Income Margin-5.56%-17.77%-49.23%-46.45%-5.43%-44.22%-13.06%-45.03%4.66%0.17%13.78%
R&D2.81B3.12B3.25B3.88B4.33B--4.47B4.46B3.36B3.76B
R&D as % of Total Revenue19.28%26.67%24.47%12.23%12.43%--10.86%12.76%9.69%7.96%
Interest Expense000000-6.32B535.88M185.71M176.29M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%-15.34%1.53%0.54%0.37%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets77.42B66.16B79.08B74.86B71.08B64.43B75.06B141.44B79.10B107.20B114.92B
Total Liabilities14.58B7.09B24.79B35.66B33.09B37.35B46.52B83.76B19.20B20.43B20.77B
Total Equity62.85B59.07B54.29B39.20B37.99B27.09B28.54B57.70B60.19B87.16B94.00B
Cash12.98B6.59B11.34B11.01B3.88B5.09B2.57M22.50B12.65B26.94B10.45B
Total Debt-3.17B16.63B12.72B20.88B6.60B-----
Net Debt-------42.42B---

Cash Flow

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-4.41B-3.54B-1.54B-2.95B-2.11B2.15B1.28B-5.36B-2.48B1.51B2.61B
Investing Cash Flow-31.26B5.16B-9.51B-7.44B-472.15M-1.62B-4.65B----
Financing Cash Flow43.06B-8.06B15.94B10.03B-4.51B875.08M10.42B----
Capital Expenditure1.58B1.00B783.77M15.37B710.83M204.69M862.16M949.78M1.65B809.97M11.94B
Free Cash Flow--------6.31B-4.12B700.70M-9.33B
Dividends Paid68.89M----------
FCF to OCF-------117.70%166.38%46.38%-357.01%

Earnings

Report DateMay 19, 2016Aug 16, 2016Sep 30, 2016Dec 31, 2016May 19, 2017Aug 29, 2017Nov 29, 2017Mar 14, 2018Mar 31, 2018Aug 14, 2018Nov 14, 2018Mar 13, 2019Mar 31, 2019Aug 14, 2019Nov 13, 2019Mar 20, 2020Mar 31, 2020Jun 30, 2020Sep 30, 2020Mar 23, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Mar 11, 2022May 16, 2022Aug 16, 2022Nov 14, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Aug 14, 2024Nov 12, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------
EPS Actual8.21-22.5119.21-59.00-21.97-24.03-25.98-100.803.45-27.00-55.51-307.601.95-1.528.38-58.19-4.84-108.35-39.23-838.43-3.71-56.68-41.00-497.05-62.457.24-1595.251256.26-8.88-5.7750.81-15.50-10.701.312.566.085.0311.2715.0031.825.9510.78
Surprise------------------------------------------
TimingAfter-hoursAfter-hours--After-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-------Pre-marketPre-marketPre-marketAfter-hours------After-hoursAfter-hours-------

Key Statistics & Ratios

Market Cap122.88B
Enterprise Value132.64B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.40
Price / Book1.28
Revenue (TTM)51.20B
Gross Profit (TTM)21.05B
EBITDA4.86B
Profit Margin12.80%
Operating Margin2.17%
Return on Equity7.09%
Return on Assets0.96%
Shares Outstanding103.26M
Shares Float59.06M
Beta-0.08
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Aug 5, 20225:1